Wells Fargo & Company Aziyo Biologics, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 112 shares of AZYO stock, worth $162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112
Previous 110
1.82%
Holding current value
$162
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AZYO
# of Institutions
25Shares Held
5.69MCall Options Held
893KPut Options Held
0-
Birchview Capital, LP Burlington, VT1.66MShares$2.4 Million2.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.65MShares$2.39 Million0.15% of portfolio
-
Perkins Capital Management Inc798KShares$1.16 Million1.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD437KShares$633,0200.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA416KShares$602,7790.0% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...